Login
← Go Back
Ind-Swift Laboratories
INDSWFTLAB · Pharma > Pharmaceuticals & Drugs · Chairman: N R Munjal · MD: N R Munjal · Listing date: July 17, 1997 · Employees: 1531 · Chandigarh · http://www.indswiftlabs.com
Stock Price vs Company Growth
1d
0.8%
1w
1.0%
1m
0.1%
3m
9.1%
6m
40.8%
1y
76.3%
5y
9.1%
10y
12.9%
all
5.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 135 0.8%
125
156
Company Overview
Sales
594 Cr
Growth: -20.9%
Profit after Tax
32.7 Cr
Growth: 85.1%
Small Cap
1,171 Cr
P/E: 4.0x
Industry P/E: 31.1x
Fundamentals
Sales (Cr) ₹ 594
Growth -20.9%
EBITDA 0.0%
P/S 2.0x
Dividend 0.0%
P/E 4.0x
Book Value ₹ 148
PEG Ratio -0.2x
ROE 2.6%
P/B 0.9x
Shareholding Pattern
Institutions
Edelweiss India Special Situations Fund Ii
10.43 %
Ec Special Situations Fund
6.82 %
Ashokkumar Chandak
2.79 %
Eisaf Ii Onshore Fund
2.24 %
Sri Ganesh Biotech Private Limited
1.26 %
Promoters
Essix Biosciences Limited
21.71 %
Ind Swift Ltd
16.08 %
N.R. Munjal
1.56 %
Rishav Mehta
0.77 %
Himanshu Jain
0.69 %
Others
Increase    Decrease    No change
Company Profile Detailed
Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry. Ind-Swift Laboratories Ltd. went public in 1997 and concentrated on the manufacturing of Active Pharmaceutical Ingredients (API).
Investors (118)
arcadia....
pranav.g...
eisaf.ii...
Followers (1)
murali5